Try our beta test site
90 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
Rank Status Study
21 Recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
22 Not yet recruiting Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
Conditions: Dry Eye Syndromes;   Pterygium
Interventions: Drug: Dipyridamole;   Drug: Placebo
23 Recruiting Effect of Nursing Care on Prevention of Dry Eye
Condition: Dry Eye Syndromes
Interventions: Device: LACRIBELL®;   Device: VIDISIC® GEL
24 Recruiting Assessment of TFT by OCT in Healthy Subjects and Subjects With DES
Condition: Dry Eye Syndromes
25 Not yet recruiting Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients
Condition: Dry Eye Syndromes
Interventions: Drug: Prosicca;   Drug: Prosicca sine;   Other: Bacterial culture
26 Recruiting Point of Care Testing of Inflammatory Markers in Tears
Condition: Dry Eye Syndrome
Interventions: Other: Eye inflammation;   Other: Without eye inflammation
27 Recruiting Ocular Surface Microbiome
Condition: Dry Eye Syndromes
28 Recruiting Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: Placebo;   Other: Sham;   Drug: Cyclosporine New Ophthalmic Formulation
29 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole
30 Recruiting Safety and Efficacy of TOP1630 for Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: TOP1630 Ophthalmic Solution;   Drug: Placebo to TOP1630 Ophthalmic Solution
31 Not yet recruiting Safety and Efficacy of BRM421 for Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: BRM421
32 Recruiting Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome
Condition: Dry Eye Syndromes
Interventions: Device: Thealoz Duo Eye Drops;   Device: Optive Eye Drops;   Device: Systane Ultra Eye Drops
33 Recruiting Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
Condition: Dry Eye Syndrome
Interventions: Drug: RGN-259;   Drug: Placebo
34 Recruiting Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: HU00701;   Drug: HU007;   Drug: Restasis;   Drug: Placebo
35 Recruiting Study to Evaluate the Efficacy and Safety of CKD-350
Condition: Dry Eye Syndrome
Interventions: Drug: Xenobella;   Drug: Isotonic 0.3% Sodium Hyaluronate
36 Recruiting Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Conditions: Autoimmunity;   Dry Eye Syndrome
Intervention: Other: Cross-sectional study
37 Not yet recruiting The Effect of Eyelid Surgery on Dry Eye - a Prospective Study
Conditions: Dry Eye Syndrome;   Ptosis;   Dermatochalasis
38 Recruiting 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
Conditions: Dry Eye Syndromes;   Diabetes Mellitus
Intervention: Drug: 0.3% Sodium Hyaluronate
39 Recruiting Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy
Conditions: Keratopathy;   Sjogren's Syndrome;   GVHD - Graft-Versus-Host Disease
Interventions: Other: CBS eyedrops;   Other: PBS eyedrops
40 Recruiting Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)
Condition: Dry Eye
Interventions: Diagnostic Test: Tear Film Imager;   Diagnostic Test: Low Humidity Environmental Exposure Chamber (LH-EEC)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.